IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING
Home Page: www.pharma.us.novartis.com
De scrip tion: Man u fac turer, re searcher, de vel -
oper, im porter, ex porter, dis trib u tor, pro moter.
Prod uct ranges in clude: phar ma ceu ti cal prod ucts
(branded, pre scrip tion, non-pre scrip tion).
Established 1997.
Con tacts (Pharm): Chair man: Burt Rosen,
Paulo Costa; Com mer cial Op er a tions: Burt Rosen;
Mar ket Re search: J. Ziemers; Re search & De vel -
op ment: D. Hauser, R. Calipre, Paul Sekhri
Par ent of: Novogyne, USA (51%).
Sub sid iary of: Novartis, Swit zer land (100%)
Phar ma ceu ti cal Sales: US$ 9,100-9,200 mil -
lion
Prod ucts (% of Sales by Lead ing 5): 50-55%
Ther a peu tic Classes (% of Sales by Lead ing
5): 65-70%
Dose Forms (% of Sales by Lead ing 5):
90-95%
Prin ci pal Prod ucts:
DIOVAN (an gio ten sin-II an tag o nist plain)
DIOVAN HCT (an gio ten sin-II an tag o nist com bi na -
tion)
GLEEVEC (antineoplastic other)
ZOMETA (bone cal cium reg u la tor)
FEMARA (cytostatic hor mone an tag o nist)
Ther a peu tic Range:
renin-an gio ten sin sys tem agents 38%
antineoplastics 10%
musculoskeletal drugs other 9%
cytostatic hor mone ther apy 5%
hor mones pi tu itary and hy po tha lamic 5%
Lead ing Dose Forms:
tab lets 44%
coated tab lets 20%
cap sules 12%
in fu sions 9%
liq uids 5%
NOVARTIS VAC CINES
Full Name: Novartis Vac cines & Di ag nos tics
Head quar ters
Street Ad dress: 4560 Hor ton Street, Emeryville,
Cal i for nia 94608-2916
Tel: +1 510 655 8730
Fax: +1 510 655 9910
Home Page: www.novartisvaccines.com
Sub sid iary of: Novartis, Swit zer land (100%)
Phar ma ceu ti cal Sales: US$ 200-210 mil lion
Prod ucts (% of Sales by Lead ing 5):
95-100%
Ther a peu tic Classes (% of Sales by Lead ing
5): n.a.
Dose Forms (% of Sales by Lead ing 5): n.a.
Prin ci pal Prod ucts:
FLUVIRIN (vac cine pure)
RABAVERT (vac cine pure)
Ther a peu tic Range:
vac cines 100%
Lead ing Dose Forms:
vi als 93%
pre-filled sy ringes/pens 7%
SANDOZ
Full Name: Sandoz, Inc.
Street Ad dress: 506 Car ne gie Cen ter, Suite
400, Prince ton, New Jer sey 08540
Tel: +1 609 627 8500
Fax: +1 609 627 8659
Home Page: www.us.sandoz.com
De scrip tion: De vel oper, man u fac turer, for mu la -
tor, dis trib u tor, sales/detailer. Dis trib utes, pro -
motes, sells/de tails for other com pa nies. Prod uct
ranges in clude: phar ma ceu ti cal prod ucts
(unbranded, pre scrip tion), hos pi tal
pharmaceuticals. Es tab lished 1946. 1,250 phar -
ma ceu ti cal employees in 2007.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 1-10 (2007)
Con tacts (Pharm): Chair man: Bernhard
Hampl; Com mer cial Op er a tions: Frank Della Fera;
Mar ket Re search: Barbara Purcell; Gen eral Con -
tact: Frank Della Fera
Sub sid iary of: Novartis, Swit zer land (100%)
Phar ma ceu ti cal Sales: US$ 2,700-2,800 mil -
lion
Prod ucts (% of Sales by Lead ing 5): 35-40%
Ther a peu tic Classes (% of Sales by Lead ing
5): 60-65%
Dose Forms (% of Sales by Lead ing 5):
85-90%
Prin ci pal Prod ucts:
METOPROLOL SUCCIN (beta-blocker agent plain)
AMLODIP BES/BENAZ (ACE in hib i tor com bi na -
tion)
FENTANYL (an al ge sic nar cotic)
AMOX TR/POT CLAVUL (pen i cil lin broad spec -
trum)
CEFDINIR (cephalosporin)
Ther a peu tic Range:
antibacterials sys temic 22%
beta-block ing agents 13%
renin-an gio ten sin sys tem agents 11%
© 2009 IMS Health In cor po rated or its af fil i ates Page 222